Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition.

Datta R, Kleinman K, Rifas-Shiman S, Placzek H, Lankiewicz J, Platt R, Huang SS.

Antimicrob Resist Infect Control. 2014 Jun 1;3:19. doi: 10.1186/2047-2994-3-19. eCollection 2014.

2.

Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: a nested case-control study.

Huang SS, Datta R, Rifas-Shiman S, Kleinman K, Placzek H, Lankiewicz JD, Platt R.

Crit Care. 2011;15(5):R210. doi: 10.1186/cc10445. Epub 2011 Sep 14.

3.

Risk factors for acquiring vancomycin-resistant Enterococcus and methicillin-resistant Staphylococcus aureus on a burn surgery step-down unit.

Wibbenmeyer L, Williams I, Ward M, Xiao X, Light T, Latenser B, Lewis R, Kealey GP, Herwaldt L.

J Burn Care Res. 2010 Mar-Apr;31(2):269-79. doi: 10.1097/BCR.0b013e3181d0f479.

PMID:
20182380
4.

Risk of acquiring antibiotic-resistant bacteria from prior room occupants.

Huang SS, Datta R, Platt R.

Arch Intern Med. 2006 Oct 9;166(18):1945-51.

PMID:
17030826
6.

The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial.

Climo MW, Sepkowitz KA, Zuccotti G, Fraser VJ, Warren DK, Perl TM, Speck K, Jernigan JA, Robles JR, Wong ES.

Crit Care Med. 2009 Jun;37(6):1858-65. doi: 10.1097/CCM.0b013e31819ffe6d.

PMID:
19384220
7.

Clinical significance of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in liver transplant recipients.

Kim YJ, Kim SI, Choi JY, Yoon SK, You YK, Kim DG.

Korean J Intern Med. 2015 Sep;30(5):694-704. doi: 10.3904/kjim.2015.30.5.694. Epub 2015 Aug 27.

8.

Effectiveness of universal screening for vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus on admission to a burn-trauma step-down unit.

Wibbenmeyer L, Appelgate D, Williams I, Light T, Latenser B, Lewis R, Kealey GP, Chen Y, Onwuameze O, Herwaldt L.

J Burn Care Res. 2009 Jul-Aug;30(4):648-56. doi: 10.1097/BCR.0b013e3181abff7e.

PMID:
19506499
9.
10.
11.

Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission.

Furuno JP, Harris AD, Wright MO, McGregor JC, Venezia RA, Zhu J, Perencevich EN.

Am J Infect Control. 2004 Dec;32(8):436-40.

PMID:
15573048
12.

Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population.

Leung W, Malhi G, Willey BM, McGeer AJ, Borgundvaag B, Thanabalan R, Gnanasuntharam P, Le B, Weizman AV, Croitoru K, Silverberg MS, Steinhart AH, Nguyen GC.

J Crohns Colitis. 2012 Aug;6(7):743-9. doi: 10.1016/j.crohns.2011.12.005. Epub 2012 Jan 9.

PMID:
22398097
13.

Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci.

Drees M, Snydman DR, Schmid CH, Barefoot L, Hansjosten K, Vue PM, Cronin M, Nasraway SA, Golan Y.

Clin Infect Dis. 2008 Mar 1;46(5):678-85. doi: 10.1086/527394.

14.
15.

Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant Gram-negative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission.

Ho PL; Hong Kong intensive care unit antimicrobial resistance study (HK-ICARE) Group.

Crit Care Med. 2003 Apr;31(4):1175-82.

PMID:
12682490
16.
17.

Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy.

Harris AD, Furuno JP, Roghmann MC, Johnson JK, Conway LJ, Venezia RA, Standiford HC, Schweizer ML, Hebden JN, Moore AC, Perencevich EN.

Antimicrob Agents Chemother. 2010 Aug;54(8):3143-8. doi: 10.1128/AAC.01590-09. Epub 2010 May 17.

18.

Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections.

McGregor JC, Perencevich EN, Furuno JP, Langenberg P, Flannery K, Zhu J, Fink JC, Bradham DD, Harris AD.

J Clin Epidemiol. 2006 Dec;59(12):1266-73. Epub 2006 Aug 10.

PMID:
17098569
19.

Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals.

Ofner-Agostini M, Varia M, Johnston L, Green K, Simor A, Amihod B, Bryce E, Henderson E, Stegenga J, Bergeron F; Canadian Nosocomial Infection Surveillance Program, Gravel D.

Am J Infect Control. 2007 Nov;35(9):563-8.

PMID:
17980232
20.

The prevalence of resistant bacterial colonization in chronic hemodialysis patients.

Hadley AC, Karchmer TB, Russell GB, McBride DG, Freedman BI.

Am J Nephrol. 2007;27(4):352-9. Epub 2007 May 26.

PMID:
17541264
Items per page

Supplemental Content

Write to the Help Desk